PRQR logo

ProQR Therapeutics N.V. Ordinary Shares


PRQR: ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.


Show PRQR Financials

Consumer Interest
SEC Filings

Recent trades of PRQR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by PRQR's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of PRQR in WallStreetBets Daily Discussion


Recent insights relating to PRQR

CNBC Recommendations

Recent picks made for PRQR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PRQR

Corporate Flights

Flights by private jets registered to PRQR